The burden of blood-pressure-related cardiovascular mortality in Mexico.

Geographical and ethnic distribution of single nucleotide polymorphisms within genes of the folate/homocysteine pathway metabolism. Genes Nutr (2014) 0.82

Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension (2003) 63.78

Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser (1995) 57.68

A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 50.94

Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet (2004) 42.12

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet (2002) 40.37

Global burden of hypertension: analysis of worldwide data. Lancet (2005) 32.76

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med (2000) 29.25

Treatment of hypertension in patients 80 years of age or older. N Engl J Med (2008) 21.04

2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens (2007) 20.09

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation (2001) 14.70

US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA (2010) 13.94

Use and misuse of population attributable fractions. Am J Public Health (1998) 12.96

2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J (2013) 12.73

Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet (2010) 11.25

Global burden of blood-pressure-related disease, 2001. Lancet (2008) 11.09

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA (2003) 9.06

Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation (2005) 8.11

Hypertension in developing countries. Lancet (2012) 3.98

Differences in prevalence, awareness, treatment and control of hypertension between developing and developed countries. J Hypertens (2009) 3.70

On the comparable quantification of health risks: lessons from the Global Burden of Disease Study. Epidemiology (1999) 3.66

The quest for universal health coverage: achieving social protection for all in Mexico. Lancet (2012) 3.48

Continued improvement in hypertension management in England: results from the Health Survey for England 2006. Hypertension (2009) 3.40

Characterizing the epidemiological transition in Mexico: national and subnational burden of diseases, injuries, and risk factors. PLoS Med (2008) 2.83

Premature deaths attributable to blood pressure in China: a prospective cohort study. Lancet (2009) 2.62

Achievement of cardiometabolic goals in aware hypertensive patients in Spain: a nationwide population-based study. Hypertension (2012) 1.55

Hypertension prevalence, awareness, treatment and control among older people in Latin America, India and China: a 10/66 cross-sectional population-based survey. J Hypertens (2012) 1.49

Systolic and diastolic blood pressure lowering as determinants of cardiovascular outcome. Hypertension (2005) 1.41

Prehypertension: epidemiology, consequences and treatment. Nat Rev Nephrol (2009) 1.28

Effect of antihypertensive therapy on incident stroke in cohorts with prehypertensive blood pressure levels: a meta-analysis of randomized controlled trials. Stroke (2011) 1.13

Hypertension in Mexican adults: results from the National Health and Nutrition Survey 2006. Salud Publica Mex (2010) 1.10

High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study. J Hypertens (2011) 1.10

Blood pressure control in Italy: analysis of clinical data from 2005-2011 surveys on hypertension. J Hypertens (2012) 1.04

[Hypertension: prevalence, early diagnosis, control and trends in Mexican adults]. Salud Publica Mex (2013) 0.98

Mortality patterns in hypertension. J Hypertens (2011) 0.90

[Cardiovascular mortality attributable to high blood pressure in Spanish population over 50]. Med Clin (Barc) (2008) 0.82

Global cardiovascular risk stratification: comparison of the Framingham method with the SCORE method in the Mexican population. Cir Cir (2011) 0.82

[Clinical guidelines for detection, prevention, diagnosis and treatment of systemic arterial hypertension in Mexico (2008)]. Arch Cardiol Mex (2008) 0.78

Achievement of cardiometabolic goals in aware hypertensive patients in Spain: implications for population health. Hypertension (2012) 0.77

Treatment of prehypertension: lifestyle and/or medication. Vasc Health Risk Manag (2012) 0.76